Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Howard I ScherProstate Cancer Clinical Trials Working Group 3

Abstract

Evolving treatments, disease phenotypes, and biology, together with a changing drug development environment, have created the need to revise castration-resistant prostate cancer (CRPC) clinical trial recommendations to succeed those from prior Prostate Cancer Clinical Trials Working Groups. An international expert committee of prostate cancer clinical investigators (the Prostate Cancer Clinical Trials Working Group 3 [PCWG3]) was reconvened and expanded and met in 2012-2015 to formulate updated criteria on the basis of emerging trial data and validation studies of the Prostate Cancer Clinical Trials Working Group 2 recommendations. PCWG3 recommends that baseline patient assessment include tumor histology, detailed records of prior systemic treatments and responses, and a detailed reporting of disease subtypes based on an anatomic pattern of metastatic spread. New recommendations for trial outcome measures include the time to event end point of symptomatic skeletal events, as well as time to first metastasis and time to progression for trials in the nonmetastatic CRPC state. PCWG3 introduces the concept of no longer clinically benefiting to underscore the distinction between first evidence of progression and the clinical need to...Continue Reading

References

Mar 10, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P SabbatiniH I Scher
May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Nov 5, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G J BubleyG Wilding
Sep 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oren SmaletzMichael W Kattan
Oct 3, 2002·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiNicholas J Vogelzang
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R SmithCelestia S Higano
Oct 13, 2006·Health and Quality of Life Outcomes·UNKNOWN U.S. Department of Health and Human Services FDA Center for Drug Evaluation and ResearchUNKNOWN U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health
Sep 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrew J ArmstrongMario Eisenberger
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew J ArmstrongMario Eisenberger
Mar 4, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherUNKNOWN Prostate Cancer Clinical Trials Working Group
May 20, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiEric J Small
Oct 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Johann S de BonoDerek Raghavan
Dec 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L H SchwartzE A Eisenhauer
Apr 22, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiEric J Small
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Sep 10, 2010·Journal of the National Cancer Institute·Axel HoosJedd Wolchok
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Jun 18, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel C DanilaHoward I Scher
Mar 1, 2012·Nuclear Medicine Communications·Matthew S BrownJonathan G Goldin
Mar 9, 2012·The New England Journal of Medicine·Marco GerlingerCharles Swanton
Apr 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J FischCharles S Cleeland
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Dec 4, 2012·European Urology·Philip J SaylorKenneth Pienta
Dec 12, 2012·The New England Journal of Medicine·Charles J RyanUNKNOWN COU-AA-302 Investigators
Mar 6, 2013·Nature Reviews. Clinical Oncology·Howard I ScherGlenn Heller
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Sep 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Matthew R SmithCarsten Goessl
Nov 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paul G KluetzRichard Pazdur
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan HalabiEric J Small
Mar 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amir GoldkornNicholas J Vogelzang
Mar 19, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David R ParkinsonGary J Kelloff
Apr 15, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Himisha BeltranMark A Rubin

❮ Previous
Next ❯

Citations

May 31, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lawrence H SchwartzElisabeth de Vries
Jun 29, 2016·Nature Reviews. Clinical Oncology·Lesley FallowfieldValerie Jenkins
Aug 17, 2016·International Journal of Molecular Sciences·Yafeng MaTherese M Becker
Sep 27, 2016·Expert Review of Anticancer Therapy·Fable Zustovich, Davide Pastorelli
Nov 8, 2016·Actas urologicas españolas·A Loizaga-IriarteM Unda-Urzaiz
Nov 9, 2016·Current Treatment Options in Oncology·Catherine E Handy, Emmanuel S Antonarakis
Dec 21, 2016·Nature Reviews. Clinical Oncology·Saskia LitièreJan Bogaerts
Mar 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark N Stein, Thomas L Jang
Apr 10, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·John O PriorWim J G Oyen
May 24, 2017·Expert Review of Anticancer Therapy·Archana Anantharaman, Eric J Small
Jun 4, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Atsushi MizokamiHiroyuki Konaka
Jun 28, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie A HarmonRobert Jeraj
Jul 2, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshiyuki KakehiUNKNOWN committee for establishment of the evidenced-based clinical practice guideline for prostate cancer of the Japanese Urologica
Jun 18, 2017·Targeted Oncology·Daniel P Petrylak, E David Crawford
Dec 14, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Thorsten D PoeppelMichael Gabriel
Mar 29, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jill M Kolesar, Glenn X Liu
Mar 23, 2018·The British Journal of Radiology·J Harvey Turner
Dec 13, 2017·Prostate Cancer and Prostatic Diseases·Michael S HumeniukAndrew J Armstrong
Apr 13, 2018·Journal of Oncology Practice·Michael J MorrisMatthew I Milowsky
Mar 10, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Suparna B WedamRichard Pazdur
Nov 4, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A Rodriguez-VidaJ Carles
Oct 6, 2017·AJR. American Journal of Roentgenology·Mario MoroneDow-Mu Koh
Apr 18, 2018·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Gary Jr Cook, Vicky Goh
Nov 15, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Kambiz RahbarHojjat Ahmadzadehfar
Nov 5, 2017·Cold Spring Harbor Perspectives in Medicine·Semini Sumanasuriya, Johann De Bono
May 10, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D LorenteJ S de Bono
Jun 7, 2018·Molecular Imaging·Kambiz RahbarHojjat Ahmadzadehfar
Jun 13, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuel S Antonarakis
Jun 28, 2018·The New England Journal of Medicine·Julia A BeaverRichard Pazdur
Mar 27, 2018·International Journal of Cancer. Journal International Du Cancer·Jelena BelicMichael R Speicher
Jul 18, 2018·Current Opinion in Supportive and Palliative Care·Samer L Traboulsi, Fred Saad

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Guru SonpavdeMatthew D Galsky
Clinical Advances in Hematology & Oncology : H&O
Tian Zhang, Andrew J Armstrong
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Howard I ScherGlenn Heller
© 2022 Meta ULC. All rights reserved